RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.

A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.

Moderna has tested its first flu and COVID combination vaccine shot. Dr. Bill Hartman from UW Health joined FOX6 to talk ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S.

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID-19 protection in one shot shows promising ...

由于每年需要分别接种1剂流感疫苗和新冠疫苗，这种接种程序的不便利导致美国两款疫苗的接种率日益下滑。为了解决这一难题、稳住新冠疫苗需求下降导致业绩持续滑坡的风险，mRNA疫苗巨头Moderna公司于昨日在美国医学会杂志（JAMA）上发表了其研发的新冠&流感病毒mRNA联合疫苗的III期临床结果。